Literature DB >> 31579902

In vitro evaluation of various antimicrobials against field mycoplasma gallisepticum and mycoplasma synoviae isolates in Egypt.

Marwa I Abd El-Hamid1, Naglaa F S Awad2, Yousreya M Hashem3, Mahmoud A Abdel-Rahman4, Adel M Abdelaziz5, Imad A A Mohammed2, Usama H Abo-Shama6.   

Abstract

Among many avian mycoplasmas, Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are recognized as the main etiological agents of respiratory diseases and infectious synovitis in chickens and turkeys causing tremendous economic losses worldwide. Therefore, proper treatment is promoted for the control of these diseases. This study was the first in Egypt to evaluate the in vitro efficacy of various antimicrobials against field MG and MS isolates recovered from chicken and turkey flocks using both conventional broth microdilution and quantitative real-time polymerase chain reaction assays. Totally, 47 mycoplasma isolates were recovered from 160 collected tracheal samples (29.4%). Of these, 44 MG (27.5%) and 3 MS (1.9%) were identified using conventional and molecular assays. The in vitro susceptibilities of 4 representative mycoplasma field isolates (3 MG and one MS) to 8 antibiotics and 4 essential oils were investigated. The tested isolates showed various susceptibilities to tested antimicrobials. Toldin CRD, followed by clove, cumin, and cinnamon oils were effective against both MG and MS clinical isolates with minimum inhibitory concentration (MIC) values ranging from 0.49 to 15.63 µg/mL. Similarly, tylvalosin was the most active antibiotic against MG and MS isolates with the lowest MIC values (0.015 to 0.03 µg/mL). DNA loads of both MG mgc2 and MS vlhA genes were markedly decreased upon treatment with majority of the tested antimicrobials confirming their effectiveness as was also evaluated by conventional MIC results. In conclusion, Toldin CRD and tylvalosin were found to be the most effective antimicrobials in this study. This finding highlights the importance of using these antimicrobials in controlling mycoplasma infections in chickens and turkeys.
© 2019 Poultry Science Association Inc.

Entities:  

Keywords:  zzm321990 Mycoplasma species; broth microdilution qRT-PCR; toldin CRD; tylvalosin

Mesh:

Substances:

Year:  2019        PMID: 31579902      PMCID: PMC8913763          DOI: 10.3382/ps/pez576

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


INTRODUCTION

Avian mycoplasmosis has been deemed as one of the most prominent economic problems in the commercial poultry industry all over the world. More than 20 species of genus Mycoplasma are known to infect avian hosts with Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) being the most clinically relevant mycoplasmas (Raviv and Ley, 2013). Mycoplasma species are transmitted horizontally by susceptible birds through direct or indirect contact with contaminated surfaces (Levisohn and Kleven, 2000) and vertically from dam to offspring through eggs (Razin and Hayflick, 2010). In geographic localities where mycoplasmosis is enzootic, programs for controlling their infections are the most practical ways to decrease the resulted economic losses. Antimicrobial therapy remains the most prompt and effective tool for treatment of mycoplasmas in poultry farms. Basically, MG and MS have shown in vitro and in vivo susceptibilities to several antimicrobials such as macrolides, tetracyclines and quinolones (Landman et al., 2008; Forrester et al., 2011). Veterinarians usually ignore the side effects of synthetic antibiotics while recommending the therapy for avian mycoplasmosis. Moreover, the development of resistance to currently used drugs (Grózner et al., 2016) incorporating with their high costs increased the need for using new and alternative antimicrobials. An approach for the development of new antimicrobials mainly from plant origin offers a great contribution in the fight against mycoplasma infections. To our knowledge, few researchers reported the efficacy of medicinal plants against different species of mycoplasma (Sabdoningrum et al., 2017; Ariela Boeder et al., 2018). Performance of phenotypic antimicrobial susceptibility tests for mycoplasmas is time-consuming and requires special techniques. Recently, quantitative real time PCR (qRT-PCR) assay has been developed as a sensitive and more specific method compared with conventional ones used in clinical microbiology laboratories (Rolain et al., 2004). Based on the above background, this study was conducted to evaluate the in vitro inhibitory effects of some essential oils and various commercial antibiotics against MG and MS field isolates using both micro-broth dilution method and qRT- PCR assays.

MATERIALS AND METHODS

Sample Collection and Study Area

The current study was carried out from January 2017 to December 2018. Three commercial broiler chicken flocks located in Faiyum, Giza and Sharkia Governorates as well as one turkey flock in El Dakhleya Governorate, Egypt were examined. The birds from Giza (50), Sharkia (50) and El Dakhleya (10) were suffering from respiratory manifestations in the form of conjunctivitis, nasal and ocular discharges, sneezing, coughing, rales and gasping while those from Faiyum (50) were suffering from both respiratory problems and synovitis. All of these flocks were not vaccinated against any mycoplasma diseases. From each flock, tracheal swabs from all diseased birds were aseptically collected and transferred in test tubes with Frey's broth medium (Oxoid, UK) as a transport medium to the laboratory until being subjected to MG and MS isolation and identification.

Ethical Statement

All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC), Faculty of Veterinary Medicine, Zagazig University.

Isolation and Identification of M. gallisepticum and M. synoviae

After incubating the broth media containing swabs for 3 to 5 d, the broth culture was streaked onto Frey's agar medium (Oxoid, UK) and incubated for 21 d. Inoculated broth and agar media were incubated under microaerophilic humid conditions (10% CO2) at 37°C. Digitonin test was then performed on the fried-egg shaped colonies. Identification of MG and MS was made by a combination of conventional biochemical methods (glucose fermentation, arginine deamination, and film and spot formation tests) and serologically via growth inhibition test using specific antisera (OIE, 2008). Further molecular identification of both MG and MS was carried out as was described previously by polymerase chain reaction (PCR) amplifications of mgc2 and vlhA genes, respectively (Zhao and Yamamoto, 1993; García et al., 2005). Known positive control MG and MS strains (accession numbers of HQ591357 and KT943466, respectively) as well as negative controls were included in every set of PCR reactions. The sizes of expected amplification products were 236 to 302 bp for mgc2 gene and 1.1 kbp for vlhA gene.

Natural Substances

The essential oils of clove (Syzygium aromaticum), cinnamon (Cinnamomum zeylanicum), and cumin (Cuminum cyminum) were purchased from National Research Centre, Egypt. Additionally, Toldin CRD (B.NO, 00101), which is a prophylactic and therapeutic agent for chronic respiratory disease (CRD) complex in poultry was kindly supplied by Dawa International for Pharmaceutical Industries, Egypt. It contains many active natural compounds such as aliumcepa, ginger, cinnamon, oregano, circumin, liqurice, anise oils, and propolis.

Antibiotics

The following 8 antibiotic agents of 5 different groups; macrolides, fluoroquinolones, tetracyclines, lincosamide, and pleuromutilins were used for the susceptibility tests: tylvalosin (Pharmgate Animal Health Canada, Inc), tilmicosin (ELANCO, Geneva), tylosin (ELANCO, USA), enrofloxacin (INVESA, Spain), doxycycline (Oxoid, UK), chlortetracycline (Oxoid, UK), lincomycin (Oxoid, UK), and tiamulin (Sandoz GmbH, Basel, Switzerland).

Antimicrobial Susceptibility Testing of Mycoplasma Isolates via broth Microdilution and qRT-PCR Assays

The antimicrobial susceptibility rates of four representative mycoplasma field isolates (one from each flock) were determined by both conventional broth microdilution (Hannan, 2000) and qRT-PCR (Hamasuna et al., 2005) assays. Briefly, each tested antimicrobial substance was two-fold serially diluted starting from a concentration of 1024 µg/mL for each antibiotic and 1000 µg/mL for each essential oil. Mycoplasma isolates were diluted to contain 103 to 104 color changing unit/0.2 mL. Consequently, 0.1 mL of each diluted substance was mixed with 0.1 mL of each diluted mycoplasma isolate in the 96-well microtiter plates. Growth controls (tested field mycoplasma strains grown into broth medium without any tested substances), sterility controls (broth medium without neither tested substances nor mycoplasma inoculum) and pH control (broth medium adjusted to pH 6.8) were included in each plate. The plates were sealed, incubated at 37°C and inspected at regular intervals for any changes in the color indicator. Each experiment was performed in triplicate and repeated twice to confirm the results. In accordance with the previously mentioned guidelines (Hannan, 2000), the initial minimum inhibitory concentration (MIC) was defined as the lowest antimicrobial concentration showing no change in colour when the colour of the mycoplasma growth control changed. The final MIC was read in the broth containing the antimicrobials at the time when no further color change was observed in the growth control wells. Quantitative RT-PCR assay was performed for determination of DNA loads using MG and MS specific primers at 2, 4, 7, and 14 d post incubation. Standard curves were prepared from 10-fold serial dilutions of genome copies of known MG and MS positive control strains to determine the DNA loads at all intervals. After amplification, a final melting curve analysis was performed to determine the presence or absence of non-specific amplification products. The inhibition rates of all tested antimicrobials were calculated according to the following formula: Inhibition rate (%) = [(average of DNA loads in control wells- DNA load in test well)/average of DNA loads in control wells] x 100. The MIC of each tested substance was defined as the lowest concentration causing 99% inhibition of mycoplasma field isolates (Hamasuna et al., 2005). Interpretation of antimicrobial susceptibility results is hampered by lacking of the official breakpoints. In these cases, interpreting the data of our study is based on values previously used in other publications (Kreizinger et al., 2017; Ariela Boeder et al., 2018).

RESULTS

Prevalence and Characterization of Avian M. gallisepticum and M. synoviae

Fried-egg-shaped pure colonies of cultured mycoplasmas were seen on Frey's agar medium. All the colonies were found sensitive to 1.5% digitonin, ensuring that they were mycoplasmas. The recovery rates of avian Mycoplasma species from 4 flocks located in different localities are illustrated in Table 1. A total of 47 mycoplasma isolates out of 160 collected tracheal samples (29.4%) were identified biochemically into 2 groups. The first group was positive for glucose fermentation test and negative for both arginine deamination and film and spot formation tests, while the second group fermented glucose, did not hydrolyse arginine and was positive for the film and spot formation test.
Table 1

Prevalence and characterization of avian M. gallisepticum and M. synoviae in 4 flocks from different localities

Biochemical characterization
Serological and molecular identification
Flock No.HostLocalityNo. of tracheal swabsNo. of positive mycoplasma isolates (%)Glucose fermentationArginine deaminationFilm and spot formationNo. of MG isolates (%)No. of MS isolates (%)
1ChickenFaiyum503 (6)++03 (6)
2Giza5025 (50)+25 (50)0
3Sharkia5016 (32)+16 (32)0
4TurkeyEl-Dakhleya103 (30)+3 (30)0
Total16047 (29.4)44 (27.5)3 (1.9)

MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae.

Prevalence and characterization of avian M. gallisepticum and M. synoviae in 4 flocks from different localities MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae. According to serological identification results using growth inhibition test, 44 (27.5%) and 3 (1.9%) were inhibited by specific antisera to MG and MS, respectively. Moreover, PCR confirmed the nucleic acid of all biochemically and serologically identified isolates with the production of the predicted amplicons to MG and MS at 236 to 302 bp and 1.1 kbp, respectively. The total recovery rate of Mycoplasma species from the examined chicken and turkey flocks were 29.3% (44/150) and 30% (3/10), respectively. Cumulatively, phenotypic and genotypic identification results confirmed that 41 isolates (27.3%) of 150 tracheal swabs from chicken flocks and 3 isolates (30%) of 10 tracheal swabs from the turkey flock in El Dakhleya were MG. In addition, MS were recovered from the chicken flocks with a percentage of 2% (3/150).

In vitro Antimicrobial Activities of Essential Oils and Antibiotics

Conventional Broth Microdilution Assay

In the first part of the study, 4 selected mycoplasma isolates (3 MG and one MS) representative for 4 flocks located in different localities were investigated. The in vitro activities of 4 different essential oils and 8 antibiotics of 5 groups against these isolates were detected by the broth microdilution technique as illustrated in Tables Table 2, Table 3, Table 4. Herein, initial MIC values were those used to evaluate the susceptibility of examined mycoplasma isolates to different antimicrobials. The in vitro MIC results of selected natural products revealed that clove, cinnamon, cumin, and Toldin CRD essential oils were variously capable for inhibiting the growth of both MG and MS clinical isolates. Toldin CRD was found to be the most effective natural substance against all tested isolates with MIC values of 0.49 to 0.98 µg/mL. Moreover, both clove and cumin oils had excellent antimycoplasmal activities with MIC ranges of 0.49 to 1.95 µg/mL and 0.98 to 3.91 µg/mL, respectively. On the other hand, cinnamon oil showed various activities from excellent to good against mycoplasma isolates with MIC values of 1.95 to 15.63 µg/mL.
Table 2

In vitro antimicrobial activities of 4 essential oils against M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods

Strain ID or median MIC valueMIC values of essential oils (μg/mL)
Clove
Cinnamon
Cumin
Toldin CRD
Conventional
Conventional
Conventional
Conventional
HostLocalityIFqRT-PCRIFqRT-PCRIFqRT-PCRIFqRT-PCR
MG1ChickenGiza0.490.490.493.917.813.911.950.980.980.980.490.98
MG2ChickenSharkia0.980.490.987.811.953.910.980.980.980.490.490.49
MG3TurkeyEl Dakhleya0.980.490.4915.630.987.813.911.953.910.980.980.49
MSChickenFaiyum1.950.983.911.950.981.950.980.980.490.490.490.49
Median MIC value0.980.745.863.911.470.980.740.49

MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: minimum inhibitory concentration, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR.

Table 3

Summary of initial and final MIC ranges (μg/mL) of the isolated M. gallisepticum and M. synoviae isolates with the suggested non-official breakpoints

Antibiotic classAntibiotic agentNon-official breakpoints (Kreizinger et al., 2017)Initial MIC rangeFinal MIC range
MacrolidesTylvalosinS ≤ 0.5; R > 20.015 to 0.030.015 to 0.125
TilmicosinS ≤ 8; R ≥ 320.06 to 0.250.25 to 0.50
TylosinS ≤ 1; R ≥ 40.060.06 to 0.25
FluoroquinolonesEnrofloxacinS ≤ 0.5; R ≥ 20.25 to 21 to 2
TetracyclinesDoxycyclineS ≤ 4; R ≥ 160.125 to 0.50.25 to 1
ChlortetracyclineS ≤ 4; R ≥ 160.5 to 162 to 16
LincosamideLincomycinS ≤ 2; R ≥ 80.25 to 22 to 8
PleuromutilinsTiamulinS ≤ 8; R ≥ 160.06 to 0.50.5

S: susceptible, R: resistant.

Table 4

Comparison between MICs of various antibiotics for M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods with their corresponding susceptibility patterns.

Strain ID or Median MIC valueMIC values (μg/mL)
TVN
TIL
TYL
EFX
DX
CTC
LCM
TIA
Conventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCRConventional
qRT-PCR
IFIFIFIF*IFIFIF*IF
MG10.015 (S)0.1250.0310.125 (S)0.250.50.06 (S)0.250.1250.25 (S)10.50.125 (S)10.250.5 (S)440.25 (S)20.250.125 (S)0.50.25
MG20.031 (S)0.1250.0310.06 (S)0.50.50.06 (S)0.250.250.5 (S)2 (R)0.50.5 (S)10.516 (R)16162 (S)8 (R)10.06 (S)0.50.5
MG30.015 (S)0.0150.0620.25 (S)0.250.250.06 (S)0.060.1252 (R)210.125 (S)0.250.1251 (S)211 (S)220.25 (S)0.50.125
MS0.015 (S)0.0150.0620.25 (S)0.250.50.06 (S)0.060.060.5 (S)2 (R)0.50.25 (S)10.252 (S)442 (S)8 (R)20.5 (S)0.50.5
Median MIC value0.020.050.190.50.060.130.50.50.190.251.541.51.50.190.38

MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: Minimum inhibitory concentration, TVN: Tylvalosin, TIL: Tilmicosin, TYL: Tylosin, EFX: Enrofloxacin, DX: Doxycycline, CTC: Chlortetracycline, LCM: Lincomycin, TIA: Tiamulin, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR.

Final MIC profiles differing from the initial ones, S: susceptible, R: resistant.

In vitro antimicrobial activities of 4 essential oils against M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: minimum inhibitory concentration, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR. Summary of initial and final MIC ranges (μg/mL) of the isolated M. gallisepticum and M. synoviae isolates with the suggested non-official breakpoints S: susceptible, R: resistant. Comparison between MICs of various antibiotics for M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods with their corresponding susceptibility patterns. MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: Minimum inhibitory concentration, TVN: Tylvalosin, TIL: Tilmicosin, TYL: Tylosin, EFX: Enrofloxacin, DX: Doxycycline, CTC: Chlortetracycline, LCM: Lincomycin, TIA: Tiamulin, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR. Final MIC profiles differing from the initial ones, S: susceptible, R: resistant. The broadest ranges of MIC values were detected for antibiotics of the macrolide group with MICs ranging from 0.015 to 0.25 µg/mL. Among the examined 3 macrolides (tylvalosin, tilmicosin and tylosin), tylvalosin was found to be the most active antibiotic in the examination with the lowest MIC values (0.015 to 0.031 µg/mL) against MG isolates and 0.015 µg/mL against the MS isolate. Moreover, tilmicosin and tylosin demonstrated also lower MICs against both MG and MS isolates (up to 0.06 µg/mL each). From the pleuromutilins, the MIC values of tiamulin were low (0.06 to 0.5 µg/mL). Among tetracyclines, the MIC values of both doxycycline and chlortetracycline showed a wide range (0.125 to 0.5 µg/mL and 0.5 to 16 µg/mL, respectively). It was obviously noted that MS isolate was sensitive to all tested antibiotics. On the other hand, all MG isolates were sensitive to tylvalosin, tilmicosin, tylosin, doxycycline, lincomycin, and tiamulin antibiotics and only 66.7% of the isolates were sensitive to each of enrofloxacin and chlortetracycline. A Comparison of initial and final MIC values showed 0 to 3-fold differences for all antibiotics. Only in the case of 6 antibiotics (tylvalosin, tilmicosin, doxycycline, chlortetracycline, lincomycin, and tiamulin), initial and final MICs exhibited up to 3-fold differences among MG isolates. Initial and final MIC values of tylvalosin, tilmicosin, tylosin and enrofloxacin for MG3 isolate and tylvalosin, tilmicosin, tylosin and tiamulin for MS isolate were the same (Table 4). Final MICs for enrofloxacin and lincomycin differed from those of the initial ones among each of MG2 and MS isolates and changed MIC profiles from sensitive to resistant.

Quantitative Real-Time PCR Assay

In the second part of our work, we quantitatively assessed the mgc2 and vlh1 gene copies when MG and MS isolates were grown in the presence of all tested antimicrobials at 2, 4, 7, and 14 d post incubation, respectively (Tables 2 and 4, Figure 1).
Figure 1

Growth inhibition rates of MG1 (A), MG2 (B), MG3 (C), and MS (D) grown into mycoplasma medium with various concentrations of tylvalosin at 2, 4, 7, and 14 d post incubation.

Growth inhibition rates of MG1 (A), MG2 (B), MG3 (C), and MS (D) grown into mycoplasma medium with various concentrations of tylvalosin at 2, 4, 7, and 14 d post incubation. The CT values of mycoplasma isolates in medium inoculated with tested substances increased with increasing the efficacy of such antimicrobials, implying that the mycoplasma loads decreased. An observable reduction in the DNA loads of both MG mgc2 and MS vlh1 genes was observed following treatment with majority of the screened substances. DNA loads of both MG and MS mgc2 and vlh1 genes were markedly decreased upon treatment with tylvalosin. Therefore, a representative model of growth inhibition rates of MG and MS isolates after exposure to various concentrations of tylvalosin at 2, 4, 7, and 14 d post incubation is shown in Figure 1. Of note, MG3 isolate had a rapid growth inhibition pattern as MIC for tylvalosin was determined early at 4 d after incubation (0.062 µg/mL). For MG1 and MG2, the MIC value was 0.031 µg/mL at 7 d after incubation. Meanwhile, MS isolate grew slowly as MIC value was determined at 14 d after incubation (0.062 µg/mL). Based on this model, MIC values of other examined antimicrobials were determined and shown in Tables 2 and 4.

Comparison between Conventional Broth Microdilution and qRT-PCR Assays for MICs Determination of Tested Antimicrobials

In Tables 2 and 4, a comparison between all MIC results obtained by conventional broth microdilution and real time PCR methods was carried out. The MICs determined by qRT-PCR assay were almost similar to the initial MICs determined by the conventional broth microdilution method for majority of the tested antimicrobials. No differences in median MIC values were observed for lincomycin (1.5 versus 1.5 µg/mL) and enrofloxacin (0.5 versus 0.5 µg/mL) using both conventional and qRT-PCR assays.

DISCUSSION

Avian mycoplasmosis is one of the most serious infectious diseases caused by Mycoplasma species, especially MG and MS. Appropriate treatment is recommended in the control of these infections in order to minimize their economic losses. In vitro antimicrobial sensitivity testing of avian Mycoplasma species has been carried out using broth microdilution method. Meanwhile, we are facing the absence of researches about the inhibitory effects of various antimicrobial substances on clinical MG and MS strains by the use of qRT-PCR as a sensitive method. Therefore, this is the first work that evaluated the in vitro susceptibilities of MG and MS isolated from chicken and turkey flocks in Egypt against various antibiotics and essential oils using both conventional broth microdilution and qRT-PCR assays. In the present study, phenotypic and genotypic identification of the recovered isolates revealed high isolation rates of Mycoplasma species from the cultured tracheal swabs of the examined chicken (29.3%) and turkey (30%) flocks. Our findings are close to those previously observed in other recent researches in Egypt, where high overall recovery rates of Mycoplasma species from chicken tracheal swabs (55.65%) (Younis et al., 2018) and from diseased turkey flocks (24%) (Hassan et al., 2012) were recorded. Another research conducted in Eastern Algeria reported also a high isolation rate of Mycoplasma species from tracheas of dead chickens (27%) (Heleili et al., 2011). The high mycoplasma prevalence rates in these investigated flocks may refer to the already acknowledged vertical transmission characteristics of mycoplasmas in addition to their horizontal transmission to the healthy susceptible birds, which amplifies the disease incidence and the subsequent economic losses. In terms of MG, the isolation rates from the diseased chickens and turkeys were 27.33 and 30%, respectively. In this regard, MG was previously isolated from 40 and 20% of chicken and turkey flocks, respectively (Eissa et al., 2011). Moreover, in other researches performed earlier, MG prevalence rates from tracheal swabs collected from broilers and turkeys were 38.71% (Younis et al., 2018) and 68% (Fadia et al., 2009), respectively. With regards to MS, a lower incidence rate was recorded from the investigated chicken flocks (2%), and it could not be also isolated previously from broilers in Iran (Gharibi et al., 2018). On the other hand, several researchers reported higher prevalence rates of MS from broiler chickens in Iran (31.25%) (Hosseini Aliabad et al., 2012), Jordan (21.7%) (Roussan et al., 2015) and Tehran province (17.89%) (Pourbakhsh et al., 2010). From our findings, cinnamon, cumin, clove oil and Toldin CRD had various antimycoplasmal activities from good to excellent with MIC values up to 0.49 µg/mL. The potent activities observed for plant extracts against mycoplasma organisms may be attributed to the anatomical structure of mycoplasma, which lacks a rigid cell wall. This feature enables the plant extracts to diffuse into the mycoplasma microorganisms, thereby causing their growth inhibition or death. The extracts were analyzed by the previous established criteria which determines that substances with MIC values <10 μg/mL are considered to have an excellent antibacterial activity, values between 10 and 100 μg/mL are considered good, values between 100 and 500 μg/mL are considered moderate, values between 500 and 1000 μg/mL are considered weak and the substances are considered inactive when MIC values are above 1000 μg/mL (Ariela Boeder et al.,2018). Toldin CRD had the best activity with an MIC of 0.49 to 0.98 µg/mL for all examined isolates. To our best knowledge, the antibacterial effects of Toldin CRD have not been described yet. It is possible that the strong antimycoplasmal activity of Toldin CRD may be explained by the presence of many active compounds, which are powerful bacteriolytic agents such as aliumcepa, ginger, cinnamon, oregano, circumin, liqurice and anise oils and propolis. The antibacterial activities of these compounds were identified previously against a large variety of pathogenic bacteria (Nabavi et al., 2015; Ariela Boeder et al., 2018). Strong antimycoplasmal capacities were also determined for both clove and cinnamon oils against both MG and MS isolates. In connection with previous researches performed on other Mycoplasma species, euganol; a major ingredient of the clove oil and cinnamon possessed bactericidal activities against M. hominis in Czech Republic (Sleha et al., 2014). One of the most remarkable results of the present study was the pronounced antibacterial property of cumin against screened mycoplasma isolates with an MIC value of 0.98 to 3.91 µg/mL. There are several studies affirmed that cumin exhibited a significant antimicrobial activity against pathogenic bacteria including Bacillus subtilis, E. coli, S. aureus, P. aeruginosa, K. pneumonea, Strept. feacalis, and S. Typhimurium (Liu et al., 2017; Owen et al., 2019). However, this is the first research that evaluates the antibacterial activity of cumin against bacteria without cell wall like mycoplasma. As our data show (Table 4), conventional microdilution results exhibited a remarkable deviation when initial and final readings were compared. Only in the case of 6 antibiotics (tylvalosin, tilmicosin, doxycycline, chlortetracycline, lincomycin, and tiamulin), initial and final MICs exhibited up to 3-fold differences among MG isolates, although it did not alter the interpretation of the data. On the other hand, final MICs for enrofloxacin and lincomycin differed from those of the initial ones among each of MG2 and MS isolates. The observed MIC differences of these antibiotics lead to the re-categorization of these isolates from susceptible to resistant during interpretation of the results. These results are consistent with a previous report carried out in Germany, where the final MICs for enrofloxacin differed from that of the initial ones including changes of the profile from sensitive to resistant among most of MS isolates (Landman et al., 2008). The discrepancies may be attributed to the inactivation of the used antibiotics with the continued incubation time (Brunner and Laber, 1985). Therefore, the initial MIC values are advised to be taken into consideration in the interpretation of the susceptibility results due to these values compare the growth of each mycoplasma isolate in the presence and absence of tested substances rather than determining the endpoint at a fixed time (Hannan, 2000). According to our results, various susceptibility rates of MG and MS isolates were observed against the eight antibiotics. Macrolides proved to have good in vitro effectiveness against both MG and MS isolates with lower MIC values ranging from 0.015 to 0.25 µg/mL. Lower MIC values for macrolides were also reported in previous examinations (Eissa et al., 2009; Forrester et al., 2011; Hassan et al., 2012; Khalil et al., 2018; Huang et al., 2019) supporting the use of these antibiotics for treatment of mycoplasmas infecting poultry in the field. Among macrolides group, tylvalosin was the most effective drug against both MG and MS isolates with an MIC range of 0.015 to 0.031 µg/mL. This finding is in a complete agreement with other research results in Iran (Behbahan et al., 2008), UK (Forrester et al., 2011) and Europe (Kreizinger et al., 2017). This could be attributed to the recent introduction of tylvalosin as a newer antibiotic against MG and MS isolates in Egypt. Our field experience supports this finding. In the present investigation, DNA loads of both MG mgc2 and MS vlhA genes were markedly decreased upon treatment with majority of the tested antimicrobials confirming the good effectiveness of these compounds. The MICs determined using qRT-PCR were almost similar to those obtained by conventional broth microdilution method. Only, a previous report in Japan was carried out to determine antibiotic susceptibility testing of M. genitalium by TaqMan 5′ nuclease qRT-PCR assay (Hamasuna et al., 2005). Recently, assessing the inhibitory effects of antibiotics using qRT-PCR assay has been also described on common clinically relevant bacterial species such as S. aureus, E. coli and Haemophilus influenzae in France (Rolain et al., 2004). In conclusion, the current study showed that Toldin CRD and tylvalosin possessed strong in vitro antimycoplasmal activities against both MG and MS field isolates. The MIC values determined using qRT-PCR were almost similar to those obtained by the conventional broth microdilution method. However, molecular detection of antimicrobial susceptibility using qRT-PCR could be more sensitive than phenotypic methods.

FUNDING

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.
  20 in total

1.  Real-time PCR for universal antibiotic susceptibility testing.

Authors:  J M Rolain; M N Mallet; P E Fournier; D Raoult
Journal:  J Antimicrob Chemother       Date:  2004-07-01       Impact factor: 5.790

2.  In vitro antibiotic susceptibility of Dutch Mycoplasma synoviae field isolates originating from joint lesions and the respiratory tract of commercial poultry.

Authors:  W J M Landman; D J Mevius; K T Veldman; A Feberwee
Journal:  Avian Pathol       Date:  2008-08       Impact factor: 3.378

3.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  A survey of Mycoplasma gallisepticum and Mycoplasma synovaie with avian influenza H9 subtype in meat-type chicken in Jordan between 2011-2015.

Authors:  Dergham Ahmad Roussan; Ghassan Khawaldeh; Ibrahim Ali Shaheen
Journal:  Poult Sci       Date:  2015-05-12       Impact factor: 3.352

5.  Molecular Identification and Sequencing of <I>Mycoplasma gallisepticum</I> Recovered from Broilers in Egypt.

Authors:  Gamal A M Younis; Rania H AbdElgawad; Rasha M Elkenany; Amira F Glal
Journal:  Pak J Biol Sci       Date:  2018-01

Review 6.  Highlights of mycoplasma research--an historical perspective.

Authors:  Shmuel Razin; Leonard Hayflick
Journal:  Biologicals       Date:  2010-02-10       Impact factor: 1.856

7.  Detection of Mycoplasma synoviae by polymerase chain reaction.

Authors:  S Zhao; R Yamamoto
Journal:  Avian Pathol       Date:  1993-09       Impact factor: 3.378

8.  Detection of Mycoplasma gallisepticum and Mycoplasma synoviae among Commercial Poultry in Khouzestan Province, Iran.

Authors:  D Gharibi; R Ghadimipour; M Mayahi
Journal:  Arch Razi Inst       Date:  2018-04-01

Review 9.  Antibacterial and Antifungal Activities of Spices.

Authors:  Qing Liu; Xiao Meng; Ya Li; Cai-Ning Zhao; Guo-Yi Tang; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2017-06-16       Impact factor: 5.923

10.  Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe.

Authors:  Zsuzsa Kreizinger; Dénes Grózner; Kinga M Sulyok; Kristin Nilsson; Veronika Hrivnák; Dušan Benčina; Miklós Gyuranecz
Journal:  BMC Vet Res       Date:  2017-11-17       Impact factor: 2.741

View more
  8 in total

1.  Detection and antibiotic resistance of Mycoplasma gallisepticum and Mycoplasma synoviae among chicken flocks in Egypt.

Authors:  Marwa Emam; Yousreya Mohamed Hashem; Mahmoud El-Hariri; Jakeen El-Jakee
Journal:  Vet World       Date:  2020-07-23

2.  Pharmacokinetics of Tylvalosin in Broiler Turkeys (Meleagris Gallopavo) After Single Intravenous and Oral Administration.

Authors:  Mohamed Elbadawy; Mohamed Aboubakr; Amira Abugomaa
Journal:  Front Vet Sci       Date:  2019-10-17

Review 3.  Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents.

Authors:  Ana R Millanao; Aracely Y Mora; Nicolás A Villagra; Sergio A Bucarey; Alejandro A Hidalgo
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

4.  Characterization and Evaluation of a Novel Conserved Membrane Antigen P35 of Mycoplasma synoviae.

Authors:  Qianjin Sun; Xiaona Wei; Wei Chen; Qian Zhong; Zhuanqiang Yan; Qingfeng Zhou; Yongchang Cao; Feng Chen
Journal:  Front Vet Sci       Date:  2022-02-23

5.  Prevalence and Antimicrobial Susceptibility of Campylobacter Species with Particular Focus on the Growth Promoting, Immunostimulant and Anti-Campylobacter jejuni Activities of Eugenol and Trans-Cinnamaldehyde Mixture in Broiler Chickens.

Authors:  Ahmed Aljazzar; Marwa I Abd El-Hamid; Rania M S El-Malt; Waleed Rizk El-Gharreb; Sherief M Abdel-Raheem; Abdelazim M Ibrahim; Adel M Abdelaziz; Doaa Ibrahim
Journal:  Animals (Basel)       Date:  2022-04-01       Impact factor: 2.752

6.  Therapeutic potentials of aivlosin and/or zinc oxide nanoparticles against Mycoplasma gallisepticum and/or Ornithobacterium rhinotracheale with a special reference to the effect of zinc oxide nanoparticles on aivlosin tissue residues: an in vivo approach.

Authors:  Naglaa F S Awad; Yousreya M Hashem; Nahla S Elshater; Eman Khalifa; Rehab I Hamed; Heba H Nossieur; Ehab M Abd-Allah; Sara T Elazab; Mohamed A Nassan; Marwa I Abd El-Hamid
Journal:  Poult Sci       Date:  2022-03-26       Impact factor: 4.014

7.  Prevalence and Antimicrobial Susceptibility of Bovine Mycoplasma Species in Egypt.

Authors:  Ahmed M Ammar; Marwa I Abd El-Hamid; Yousreya H Mohamed; Heba M Mohamed; Dalal H M Al-Khalifah; Wael N Hozzein; Samy Selim; Wafaa M El-Neshwy; Rania M S El-Malt
Journal:  Biology (Basel)       Date:  2022-07-20

8.  Modulatory Impacts of Multi-Strain Probiotics on Rabbits' Growth, Nutrient Transporters, Tight Junctions and Immune System to Fight against Listeria monocytogenes Infection.

Authors:  Marwa I Abd El-Hamid; Doaa Ibrahim; Rehab I Hamed; Heba H Nossieur; Mariam Hassan Elbanna; Heba Baz; Ehab M Abd-Allah; Amal S A El Oksh; Ghada A Ibrahim; Eman Khalifa; Tamer Ahmed Ismail; Naglaa F S Awad
Journal:  Animals (Basel)       Date:  2022-08-15       Impact factor: 3.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.